Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda,and trends of resistance between 1986 and 2000

Citation
E. Van Dyck et al., Antimicrobial susceptibilities of Neisseria gonorrhoeae in Kigali, Rwanda,and trends of resistance between 1986 and 2000, SEX TRA DIS, 28(9), 2001, pp. 539-545
Citations number
57
Categorie Soggetti
Clinical Immunolgy & Infectious Disease","da verificare
Journal title
SEXUALLY TRANSMITTED DISEASES
ISSN journal
01485717 → ACNP
Volume
28
Issue
9
Year of publication
2001
Pages
539 - 545
Database
ISI
SICI code
0148-5717(200109)28:9<539:ASONGI>2.0.ZU;2-0
Abstract
Background: Plasmid-mediated and chromosomal-mediated resistance of Neisser ia gonorrhoeae to penicillin, tetracycline, thiamphenicol, and trimethoprim -sulfamethoxazole has spread dramatically in Africa. Monitoring of antimicr obial susceptibility is a key element in the control of sexually transmitte d diseases. Goal: To document antimicrobial susceptibilities of gonococci isolated duri ng the past 15 years in Kigali, Rwanda. Study Design: Minimal inhibitory concentrations of recently collected gonoc occal isolates of eight antimicrobials were determined. The results were co mpared with data collected for isolates obtained since 1986. Results: In 1986, 35% of the gonococcal isolates were penicillinase-produci ng N gonorrhoeae. Tetracycline-resistant N gonorrhoeae appeared in 1989. Th e prevalence of penicillinase-producing N gonorrhoeae and tetracycline-resi stant N gonorrhoeae increased significantly to 70.5% and 89.2%, respectivel y. Chromosomal resistance to penicillin, tetracycline, an thiamphenicol inc reased temporarily, then decreased significantly. Chromosomal resistance to trimethoprim-sulfamethox-azole appeared in 1988 and increased to 21.6%. Al l the isolates were susceptible to ceftriaxone, ciprofloxacin, spectinomyci n, and kanamycin. Conclusions: This study illustrated the rapidly increasing frequencies of p enicillinase-producing N gonorrhoeae and tetracycline-resistant N gonorrhoe ae. Chromosomal resistance to thiamphenicol and trimethoprim-sulfamethoxazo le excludes these drugs as alternative treatment. Programs for antimicrobia l susceptibility surveillance of N gonorrhoeae should urgently be establish ed in Africa.